NTLA Today - Aug 07: Stock Up After Upgrade

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

NTLA Today - Aug 07: Stock Up After Upgrade

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor, here to break down the day for you. Today, we’re talking about Intellia, or NTLA for short. It was a green day for them, up about 5.4%. Nice little boost, right?

So, what went down? NTLA had a solid day on the market. The stock jumped up after some upgrades and buzz around their research. People were feeling good about the potential of their treatments, especially with the Phase III data coming in. That’s always a good sign for investors.

Now, the why behind this move is pretty interesting. Evercore ISI gave them an upgrade, which definitely helped turn some heads. They’re looking at the nex-z hypothesis, which sounds fancy but basically means they’re excited about the future of Intellia’s treatments. Plus, there was chatter about their ATTR program being back in the game. When you’ve got news like that, it gets folks talking and buying in.

Oh, and here’s a quick heads-up: they just wrapped up their Q2 earnings call, so there might be more details coming out soon that could shake things up again. Always good to keep an eye on that.

So yeah, things are looking a little brighter for Intellia today. It’s always a bit of a rollercoaster with biotech stocks, but today was definitely a win. Just remember, I’m here to share the info, not give any financial advice. Catch you later!

まだレビューはありません